Medicare Enrolled
Dr. Lester Robertson, M.D.
Hematology & Oncology · Savannah, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Robertson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Robertson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Robertson
Dr. Lester Robertson is a hematology & oncology specialist in Savannah, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Robertson performed 7,224 Medicare services across 1,003 unique beneficiaries.
Between the years covered by Open Payments, Dr. Robertson received a total of $19,099 from 81 pharmaceutical and/or device companies across 953 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Robertson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 19% volume in GA
$19,099 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,224
Medicare services
Top 19% in GA for hematology & oncology
1,003
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~380 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 4,980 | $18 | $74 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
749 | $89 | $366 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
378 | $58 | $259 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
260 | $0 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
226 | $8 | $32 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
116 | $10 | $40 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
91 | $131 | $518 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
90 | $90 | $296 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
83 | $63 | $258 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
75 | $60 | $206 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
59 | $84 | $366 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
49 | $37 | $158 |
| New patient office visit, complex (60-74 min) | 38 | $161 | $636 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $125 | $480 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $132 | $572 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$19,099
Total received (2018-2024)
Avg $2,728/year across 7 years
Top 20% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
953
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,973 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$125 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,555
2023
$2,774
2022
$2,727
2021
$1,814
2020
$1,241
2019
$4,444
2018
$3,545
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$327
AstraZeneca Pharmaceuticals LP
$271
Novartis Pharmaceuticals Corporation
$252
E.R. Squibb & Sons, L.L.C.
$217
Merck Sharp & Dohme LLC
$204
ABBVIE INC.
$188
Gilead Sciences, Inc.
$98
Stemline Therapeutics Inc.
$89
Genentech USA, Inc.
$87
BeiGene USA, Inc.
$81
Regeneron Healthcare Solutions, Inc.
$68
GlaxoSmithKline, LLC.
$61
Eisai Inc.
$59
Astellas Pharma US Inc
$54
Takeda Pharmaceuticals U.S.A., Inc.
$52
Deciphera Pharmaceuticals Inc.
$50
Daiichi Sankyo Inc.
$47
ARRAY BIOPHARMA INC
$47
Ipsen Biopharmaceuticals, Inc
$44
Alexion Pharmaceuticals, Inc.
$43
Kite Pharma, Inc.
$40
Janssen Biotech, Inc.
$31
Acrotech Biopharma Inc.
$27
EMD Serono, Inc.
$22
Exelixis Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$21
SOBI, INC
$18
PUMA BIOTECHNOLOGY, INC.
$18
SERVIER PHARMACEUTICALS LLC
$16
Top 3 companies account for 33.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$4,448
Amgen Inc.
$1,150
Genentech USA, Inc.
$923
PFIZER INC.
$840
AstraZeneca Pharmaceuticals LP
$778
E.R. Squibb & Sons, L.L.C.
$734
Merck Sharp & Dohme LLC
$612
Merck Sharp & Dohme Corporation
$605
Janssen Biotech, Inc.
$557
Celgene Corporation
$551
Regeneron Healthcare Solutions, Inc.
$511
Lilly USA, LLC
$436
GENZYME CORPORATION
$435
Daiichi Sankyo Inc.
$412
Astellas Pharma US Inc
$380
Gilead Sciences, Inc.
$324
Bayer HealthCare Pharmaceuticals Inc.
$316
Takeda Pharmaceuticals U.S.A., Inc.
$298
NOVARTIS PHARMACEUTICALS CORPORATION
$256
Ipsen Biopharmaceuticals, Inc
$256
Seagen Inc.
$255
ABBVIE INC.
$203
Eisai Inc.
$191
EISAI INC.
$187
Pharmacyclics LLC, An AbbVie Company
$161
ARRAY BIOPHARMA INC
$159
Seattle Genetics, Inc.
$149
BeiGene USA, Inc.
$148
Incyte Corporation
$140
TESARO, Inc.
$130
Exelixis Inc.
$130
Kyowa Kirin, Inc.
$118
Alexion Pharmaceuticals, Inc.
$117
GlaxoSmithKline, LLC.
$114
Taiho Oncology, Inc.
$112
Stemline Therapeutics Inc.
$107
Boehringer Ingelheim Pharmaceuticals, Inc.
$104
Kite Pharma, Inc.
$98
AbbVie, Inc.
$96
Acrotech Biopharma LLC
$87
Puma Biotechnology, Inc.
$87
Acrotech Biopharma Inc.
$85
TerSera Therapeutics LLC
$75
JAZZ PHARMACEUTICALS INC.
$71
PUMA BIOTECHNOLOGY, INC.
$69
Myovant Sciences Inc.
$68
MEDIVATION FIELD SOLUTIONS LLC
$56
AMAG Pharmaceuticals, Inc.
$53
Deciphera Pharmaceuticals Inc.
$50
Teva Pharmaceuticals USA, Inc.
$48
Clovis Oncology, Inc.
$43
MorphoSys, US Inc.
$43
Rigel Pharmaceuticals, Inc.
$42
Karyopharm Therapeutics Inc.
$41
G1 Therapeutics, Inc.
$37
Sumitomo Pharma America, Inc.
$37
AbbVie Inc.
$36
Bayer Healthcare Pharmaceuticals Inc.
$34
Janssen Pharmaceuticals, Inc
$34
EMD Serono, Inc.
$34
TAIHO ONCOLOGY, INC.
$33
Mylan Institutional Inc.
$33
Dova Pharmaceuticals
$31
Global Blood Therapeutics, Inc.
$27
CSL Behring
$25
Pharmacosmos Therapeutics Inc.
$25
Heron Therapeutics, Inc.
$24
EUSA Pharma (US) LLC
$22
Sun Pharmaceutical Industries Inc.
$21
Sobi, Inc
$21
Octapharma USA, Inc.
$19
SOBI, INC
$18
GE HealthCare
$18
CTI BioPharma Corp.
$16
AVEO Pharmaceuticals, Inc.
$16
SERVIER PHARMACEUTICALS LLC
$16
Shire North American Group Inc
$14
Jazz Pharmaceuticals Inc.
$14
SANOFI-AVENTIS U.S. LLC
$13
SUN PHARMACEUTICAL INDUSTRIES INC.
$11
Secura Bio, Inc.
$10
Top 3 companies account for 34.1% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · ALIMTA · AUGTYRO · Abraxane · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · Enhertu · Erleada · FARESTON · FASLODEX · FEMARA · FERAHEME · FOLOTYN · FOTIVDA · FRUZAQLA · Fabhalta · Farydak · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idelvion · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Ogivri · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VPRIV · VYXEOS · Venclexta · Vitrakvi · Vonjo · WELIREG · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
11
Per 100K population
3.7
County median income
$69,575
Nearest hospital
CANDLER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Robertson is a clinical cardiology specialist, with above-average Medicare volume (top 19% in GA), with low-engagement industry engagement in the top 20% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Robertson experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Robertson performed 4,980 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Robertson receive payments from pharmaceutical companies?
Yes. Dr. Robertson received a total of $19,099 from 81 companies across 953 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Robertson's costs compare to other hematology & oncology specialists in Savannah?
Dr. Robertson's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Robertson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Savannah
Browse hematology & oncology specialists in Savannah ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology